Unipath tests techno-rhythm method:
This article was originally published in Clinica
Executive Summary
A hi-tech version of the rhythm method is recruiting women for trials in Europe. Unipath's (UK) Personal Contraceptive System uses a hand-held monitor to read urine test sticks. The monitor has been nick-named "the sex traffic light" because it indicates fertility status with red and green lights. While one would like to think that all methods of contraception are, ipso facto, personal, Unipath explains that the monitor records a user's hormone levels on a six-month rolling basis, and uses these to personalise its algorithm. The independently- co-ordinated trials will enrol 1,200 women in Germany, Ireland and the UK.
You may also be interested in...
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
P&G Restores Volume Growth In Beauty, Grooming After Pricing Run
Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.
BMS Has A Strong Pipeline, But Access Challenges Remain
Bristol Myers Squibb’s head of major markets, Monica Shaw, wants to improve patients’ access to lifesaving therapies. And the group has several new products ready to roll.